Spirometry values in a Greek population: Is there an appropriate reference equation?

Background and objective: Most published reference values for lung function test (LFT) parameters introduce systematic bias. The aim of this study was to compare measured values of FEV₁ and FVC with the corresponding normal predicted values in a Greek population, and to produce reference equations for LFT parameters in this population. Methods: In a cross‐sectional study conducted in Macedonia, Greece, 1080 adult healthy, non‐smokers (432 men, 648 women, aged 18–80 years), underwent spirometry. Measured values of FVC and FEV₁ were compared with predicted values determined using three existing sets of reference equations: one recently derived from a European population and two others widely used in Europe (European Coal and Steel Community; ECSC) and the USA (National Health and Nutrition Examination Survey; NHANES III). Height and age were entered into the multivariate regression analysis to produce reference equations for LFT parameters. Results: All three published sets of equations underpredicted FEV₁ in men. FVC was accurately predicted by all equations except NHANES III. The discrepancy was even greater among women; the ECSC equation underpredicted both FEV₁ and FVC, the NHANES III equation overpredicted both FEV₁ and FVC, while the third set of equations accurately predicted FEV₁ but overpredicted FVC. The derived reference equation for FEV₁ in men was ?0.28 × age + 0.057 × height ? 4.91, and in women ?0.021 × age + 0.039 × height ? 2.58. The derived reference equation for FVC in men was ?0.28 × age + 0.071 × height ? 6.763, and in women ?0.019 × age + 0.056 × height ? 5.018. Conclusions: Measured FEV₁ and FVC values in a Greek population differed significantly from those predicted using previously published reference equations. The new locally derived spirometry reference equations may be more suitable for evaluation of lung function in everyday practice.     

Normal Spirometric Reference Values for Omani Adults

International guidelines recommend the use of population-specific reference values to eliminate the well-recognized influence of ethnic variation on lung function. This study was designed to derive spirometric prediction equations for healthy Omani adults. Forced vital capacity (FVC), forced expiratory volume in one second (FEV₁), peak expiratory flow rate (PEFR), and forced expiratory flow at 25% to 75% of FVC (FEF_25–75%) were measured in 419 “healthy” nonsmoking Omani adults (256 men, 163 women), aged 18–65 years. Multiple linear regression analysis was performed for each spirometric parameter against age, height, and weight for men and women separately, and prediction equations for all the above parameters were derived and compared with values derived using equations published from other populations. All measured spirometric parameters increased with height and decreased with age, and they were all significantly higher in men. In contrast, FEV₁/FVC% values decreased with height and increased with age and were higher in women. The predicted normal values of FVC and FEV₁ for our subjects using the derived equations were lower by 7–17% compared with respective Caucasian values, with smaller difference in the predicted values of PEFR, FEV₁/FVC%, and FEF_25–75%. This report presents previously unavailable spirometric reference equations for the Omani adults. Our findings highlight the need to use reference values based on updated data derived from relevant populations.     

Genetic Influences on Pulmonary Function: A Large Sample Twin Study

Heritability of forced expiratory volume in one second (FEV₁), forced vital capacity (FVC), and peak expiratory flow (PEF) has not been previously addressed in large twin studies. We evaluated the genetic contribution to individual differences observed in FEV₁, FVC, and PEF using data from the largest population-based twin study on spirometry. Specially trained lay interviewers with previous experience in spirometric measurements tested 4,314 Danish twins (individuals), 46–68 years of age, in their homes using a hand-held spirometer, and their flow-volume curves were evaluated. Modern variance component sex-limitation models were applied to evaluate possible genetic differences between the sexes for FEV₁, FVC, and PEF. Estimates were adjusted for age, height, and smoking. For FEV₁, additive genetic effects of 61% (95% CI 56–65) were observed. For FVC, the additive genetic contribution was 26% (3–49%) and the dominant genetic contribution was 29% (4–54%). For PEF, our models showed an additive genetic contribution of 43% (31–52%) for men, but genetic influences were not significant in women. We found no significant differences between dizygotic same-sex twins and dizygotic opposite-sex twins for FEV₁, FVC, and PEF, suggesting absence of qualitative genetic differences between the sexes. Sex-difference heritability for PEF suggested possible quantitative genetic differences between the sexes for this index. Genetic effects contributed significantly to individual differences observed in FEV₁, FVC, and PEF. Qualitative sex differences were absent for all spirometric measures, while quantitative sex differences were observed only for PEF, with heritability being substantial in men but negligible in women.     

Canadian prediction equations of spirometric lung function for Caucasian adults 20 to 90 years of age: results from the Canadian Obstructive Lung Disease (COLD) study and the Lung Health Canadian Environment (LHCE) study

BACKGROUND:

Currently, no reference or normative values for spirometry based on a randomly selected Canadian population exist.

OBJECTIVE:

The aim of the present analysis was to construct spirometric reference values for Canadian adults 20 to 90 years of age by combining data collected from healthy lifelong nonsmokers in two population-based studies.

METHOD:

Both studies similarly used random population sampling, conducted using validated epidemiological protocols in the Canadian Obstructive Lung Disease study, and the Lung Health Canadian Environment study. Spirometric lung function data were available from 3042 subjects in the COLD study, which was completed in 2009, and from 2571 subjects in the LHCE study completed in 1995. A total of 844 subjects 40 to 90 years of age, and 812 subjects 20 to 44 years of age, were identified as healthy, asymptomatic, lifelong nonsmokers, and provided normative reference values for spirometry. Multiple regression models were constructed separately for Caucasian men and women for the following spirometric parameters: forced expiratory volume in 1 s (FEV₁), forced vital capacity (FVC) and FEV₁/FVC ratio, with covariates of height, sex and age. Comparison with published regression equations showed that the best agreement was obtained from data derived from random populations.

RESULTS:

The best-fitting regression models for healthy, never-smoking, asymptomatic European-Canadian men and women 20 to 90 years of age were constructed. When age- and height-corrected FEV₁, FVC and FEV₁/FVC ratio were compared with other spirometry reference studies, mean values were similar, with the closest being derived from population-based studies.

CONCLUSION:

These spirometry reference equations, derived from randomly selected population-based cohorts with stringently monitored lung function measurements, provide data currently lacking in Canada.     

Effect of tobacco smoking, respiratory symptoms and asthma on spirometry among adults attending a check-up clinic in Mexico City

OBJECTIVE: To evaluate the effect of tobacco smoking, respiratory symptoms, and asthma on lung function among Mexican adults who were evaluated during a medical exam in a private health clinic. MATERIAL AND METHODS: Reference prediction equations were generated for spirometry parameters [forced vital capacity (FVC), forced expired volume in one second (FEV1) and FEV1/FVC] based on multiple linear regression models. The effect of tobacco smoking, respiratory symptoms and asthma on these equations were explored. RESULTS: Spirometry tests were performed on 919 subjects from 14 to 86 years of age.Asthma decreased FVC and FEV1 in men with a R2 change <1%. Respiratory symptoms decreased the FEV1/FVC ratio in both sexes.Tobacco smoking was associated with a significant reduction in FEV in women. CONCLUSIONS: Asthma lightly reduced lung function in males while tobacco smoking decreased FEV, particularly in females.     

Prediction of maximum voluntary ventilation (MVV) in African-American adolescent girls

The purposes of the present study were to: (1) develop original equations to predict maximum voluntary ventilation (MVV) in African-American adolescent girls; and (2) determine the validity of existing MVV prediction equations for use in African-American subjects by comparing predicted MVV values in the literature with actual MVV values obtained in this study. Forced expiratory volume in 1 second (FEV₁), forced vital capacity (FVC), and 12 second MVV were measured with a clinical respirometer (Spirometrics model 2451) in 93 African-American adolescent girls (13.5 ± 1.0 years). Age (r = 0.29). height (r = 0.38), FEV₁ (r = 0.52), and FVC (r = 0.48) were significantly (P < 0.01) correlated with MVV. Multiple regression analysis was used to develop equations to predict MVV with age, height, and FEV₁ as predictor variables. Using Mallow's C_p criterion, age-FEV₁ and FEV₁, equations appeared to be the most accurate predictors of MVV. When MVV was regressed on FEV₁, in a no-intercept model, the result was the commonly cited equation MVV = 35.0 × FEV₁. Thus, the previously established relationship between FEV₁ and MVV can be extended to African-American adolescent girls. Comparison of predicted MVV values calculated from other published equations with our subjects' actual values indicated that equations using age and/or height as predictors did not accurately predict MVV in our subjects. Pediatr Pulmonol. 1995; 20:225–233 . © 1995 Wiley-Liss, Inc.     

Spirometric pulmonary function parameters of healthy Chinese children aged 3–6 years in Taiwan

Spirometry is a well‐known technique for evaluating pulmonary function, but few studies have focused on preschool children. The aim of this study was to determine reference values of forced spirometric parameters in young Chinese children, aged 3–6 years, in Taiwan. Spirometric measurements were performed at day care centers by experienced pediatricians. Of 248 children without a history of chronic respiratory illness, at least two valid spirometric attempts were obtained from 214 children (109 boys and 105 girls; age: 36–83 [mean = 61] months; height: 90–131 [mean = 111] cm). Values of forced expiratory volume in 1 sec (FEV₁) and 0.5 sec (FEV_0.5), forced vital capacity (FVC), peak expiratory flow rate (PEF), forced expiratory between 25% and 75% FVC (FEF_25–75), and forced expiratory flow rate at 25%, 50%, and 75% of FVC (FEF₂₅, FEF₅₀, and FEF₇₅) were derived and analyzed. There were significant positive correlations between study parameters and body height, body weight, and age. Height was the most consistently correlated measurement in both boys and girls. Although boys tended to have higher spirometric values than girls, we found significant differences only in FVC and FEV₁ between boys and girls aged 6 years. The regression equations of each parameter were obtained. In conclusion, spirometric pulmonary function tests are feasible in 3‐ to 6‐year‐old children. The obtained values and regression equations provide a reference for Chinese preschool children and may be of value in evaluating pulmonary function of children with respiratory problems in this age group. Pediatr Pulmonol. 2009; 44:676–682. © 2009 Wiley‐Liss, Inc.     

Post-bronchodilator spirometry reference values in adults and implications for disease management

RATIONALE: International guidelines promote the use of post-bronchodilator spirometry values in the definition and severity classification of chronic obstructive pulmonary disease. However, post-bronchodilator reference values have not yet been developed. OBJECTIVES: To derive reference values for post-bronchodilator forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and FEV1/FVC, and to compare these reference values with locally derived and existing pre-bronchodilator reference values. METHODS: Based on a random sample of a general adult population, 2,235 subjects (70% of invited subjects) performed spirometry with reversibility testing. A reference population of healthy never-smokers constituted 23% of the study population (n=515). Reference values for median and lower-limit-of-normal pre- and post-bronchodilator lung function and bronchodilator response were modeled using quantile regression analyses. MAIN RESULTS: The reference population had equal proportions of men and women in the age range 26-82 yr. Both FEV1 and FVC decreased with age and increased with height. FEV1/FVC decreased with age, although this trend was not statistically significant for men after bronchodilatation. Linear models gave the best overall fit. Lower-limit-of-normal post-bronchodilator FEV1/FVC exceeded 0.7 for both sexes. Post-bronchodilator prediction equations gave higher predicted FEV1 and FEV1/FVC than both locally derived and existing pre-bronchodilator equations. The bronchodilator response decreased with age. CONCLUSIONS: The present study is the first to develop reference values for post-bronchodilator lung function. Post-bronchodilator prediction equations can facilitate better management of patients with chronic obstructive pulmonary disease by avoiding falsely high FEV1% predicted with a subsequent underestimation of disease severity.     

Spirometric reference equations for European females and males aged 65-85 yrs.

The aim of this study was to describe spirometric reference equations for healthy never-smoking European adults aged 65-85 yrs and to compare the predicted values of this sample with those from other studies including middle-aged and/or older adults. Reference equations and normal ranges for forced expiratory volume in one second (FEV1), forced vital capacity (FVC), forced expiratory volume in six seconds (FEV6), FEV1/FVC ratio and FEV1/FEV6 ratio were derived from a healthy subgroup of 458 subjects aged 65-85 yrs. Spirometry examinations followed the 1994 American Thoracic Society recommendations and the quality of the data was continuously monitored and maintained. Reference values and lower limits of normal were derived using a piecewise polynomial model with age and height as predictors. The reference values of FEV1 and FVC from the present study were higher than those given by prediction equations from the European Community for Coal and Steel. By contrast, use of prediction equations from Caucasian-American elderly subjects (Cardiovascular Health Study) consistently overpredicted FVC and FEV1 in females by 8.5 and 2.1%, respectively. In males, equations from the Cardiovascular Health Study overpredicted FVC by 2.8%, whilst underpredicting FEV1 by 2.5%. In conclusion, these results underscore the importance of using prediction equations appropriate to the origin, age and height characteristics of the subjects being studied.     

What is the difference between FEV1 change in percentage predicted value and change over baseline in the assessment of bronchodilator responsiveness in patients with COPD?

Background

Several criteria are clinically applied in the assessment of significant bronchodilator responsiveness in chronic obstructive pulmonary disease (COPD). The present study aimed to investigate the differences in various degree of severity of COPD among these criteria.

Methods

After 400 micrograms of salbutamol administered via spacer by metered dose inhaler (MDI), forced expiratory volume in one second (FEV₁) and forced vital capacity (FVC) changes (including percentage change, absolute change and absolute change in percentage predicted value) were retrospectively analysed in 933 stable patients with mild-to-very-severe COPD. Significant bronchodilator responsiveness was assessed using American Thoracic Society and European Respiratory Society (ATS-ERS) criterion based on FEV₁ or/and FVC (both ≥12% increase over baseline and ≥200 mL) and FEV₁ percentage predicted criterion (≥10% absolute increase in percentage predicted FEV₁) in different grades of COPD.

Results

Of the patients [age 66.8 years, baseline FEV₁ 974 mL (39.3% predicted) and FVC 2,242 mL], mean improvements were 126 mL in FEV₁ and 265 mL in FVC; 21.4% and 45.3% met ATS-ERS criterion based on FEV₁ and FVC, respectively; and 13.5% met FEV₁ percentage predicted criterion. The responsive ratios of ATS-ERS criterion based on FEV₁ to FEV₁ percentage predicted criterion in grade I, II, III and IV of COPD were 0.95^:1.26^:2.53^:6.00, respectively (P<0.01 in grade II and P<0.001 in grade III). As the degree of severity increased, the mean improvement of FEV₁ was reduced; on the contrary, that of FVC was increased.

Conclusions

Compared with FEV₁ percentage predicted criterion, ATS-ERS criterion based on FEV₁ as well as FVC, the later in particular, detected a larger percentage of patients with significant responsiveness. The increasing difference was relevant as a function of the severity of airflow obstruction.KEY WORDS : Airflow obstruction, bronchodilator responsiveness, chronic obstructive pulmonary disease (COPD), forced vital capacity (FVC), forced expiratory volume in one second (FEV₁)     

Lung function values in healthy non-smoking urban adults in iran

BACKGROUND: The values of lung function tests (LFTs) are dependent on height, age, and sex. In addition, there is evidence of LFT variation in different ethnic groups. OBJECTIVE: We have therefore derived prediction equations for LFTs from a healthy, non-smoking, urban adult population in the city of Mashhad (northeast Iran). METHODS: Predicted equations for normal lung function have been derived from 572 healthy, non-smoking subjects including 326 men (height 154-195 cm) and 246 women (height 144-174 cm) aged 18-65 years. The subjects underwent measurement of spirometric flow and volume. The following variables were measured: forced vital capacity (FVC), forced expiratory volume in 1 s (FEV(1)), maximal mid-expiratory flow (MMEF), peak expiratory flow (PEF) and maximal expiratory flow at 75, 50 and 25% of the FVC (MEF(75), MEF(50), and MEF(25), respectively). Regression analysis using height and age as independent variables was applied to provide predicted values for both sexes. RESULTS: There was a negative correlation between each lung function and age. The largest negative correlations were found for FEV(1) and FVC in men and women, respectively. All parameters correlated positively with height; the largest positive correlation was observed for FVC in both sexes. Comparison of LFTs derived from the equations of the present study showed significant differences with those of several previous studies. CONCLUSION: In this study, a set of LFT reference values and prediction equations for both sexes have been derived using a relatively large, healthy, non-smoking Iranian, adult population which was different from several other prediction equations.     

Gender differences in the association between C-reactive protein, lung function impairment, and COPD

Individuals with COPD have systemic inflammation that can be assessed by measuring C-reactive protein (CRP). In this paper we evaluated whether CRP is related to COPD, lung function and rate of lung function decline.We included 1237 randomly selected subjects (mean age 42, range 28–56 years) from three centers in the European Community Respiratory Health Survey: Reykjavik, Uppsala and Tartu. CRP was measured at the end of the follow-up (mean 8.3 years) and the values were divided into 4 quartiles.Fifty-three non-asthmatic subjects fulfilled spirometric criteria for COPD (FEV₁/FVC < 70%). COPD occurred more often in the 4th CRP quartile (OR (95% CI) 3.21 (1.13–9.08)) after adjustment for age, gender, body weight and smoking. High CRP levels were related to lower FEV₁ values in both men (−437 (−596, −279) mL) and women (−144 (−243, −44) mL). The negative association between CRP and FEV₁ was significantly larger in men than women (p = 0.04). The decline in FEV₁ was larger (16 (5, 27) mL) in men with high CRP levels whereas no significant association between CRP and FEV₁ decline was found in women.Higher CRP values are significantly associated with COPD and lower lung function in men and women. In men higher CRP values are related to a larger decline in FEV₁.     

Reference values for spirometry,including vital capacity,in Japanese adults calculated with the LMS method and compared with previous values

BackgroundReference values for lung function tests should be periodically updated because of birth cohort effects and improved technology. This study updates the spirometric reference values, including vital capacity (VC), for Japanese adults and compares the new reference values with previous Japanese reference values.MethodsSpirometric data from healthy non-smokers (20,341 individuals aged 17–95 years, 67% females) were collected from 12 centers across Japan, and reference equations were derived using the LMS method. This method incorporates modeling skewness (lambda: L), mean (mu: M), and coefficient of variation (sigma: S), which are functions of sex, age, and height. In addition, the age-specific lower limits of normal (LLN) were calculated.ResultsSpirometric reference values for the 17–95-year age range and the age-dependent LLN for Japanese adults were derived. The new reference values for FEV₁ in males are smaller, while those for VC and FVC in middle age and elderly males and those for FEV₁, VC, and FVC in females are larger than the previous values. The LLN of the FEV₁/FVC for females is larger than previous values. The FVC is significantly smaller than the VC in the elderly.ConclusionsThe new reference values faithfully reflect spirometric indices and provide an age-specific LLN for the 17–95-year age range, enabling improved diagnostic accuracy. Compared with previous prediction equations, they more accurately reflect the transition in pulmonary function during young adulthood. In elderly subjects, the FVC reference values are not interchangeable with the VC values.     

Pulmonary function between 6 and 18 years of age

Pulmonary function of children aged 6–18 years is described based on 82,462 annual measurements of forced vital capacity (FVC), forced expired volume in 1 second (FEV₁), and forced expiratory flow between 25% and 75%of FVC (FEF_25–75%) from 11,630 white children and 989 black children. Median height, FVC, FEV₁ FEV₁/FVC₁ and FEF_25–75% for each 3 months of age are compared among race and sex subgroups. Race— and sex-specific percentile distributions of FVC, FEV₁, FEV₁/FVC, and FEF_25—75% are presented for each centimeter of height (growth curves). For the same height, boys have greater lung function values than girls, and whites have greater ones than blacks. Lung function increases linearly with age until the adolescent growth spurt at about age 10 years in girls and 12 in boys. The pulmonary function vs. height relationship shifts with age during adolescence. Thus, a single equation or the pulmonary function-height growth chart alone does not completely describe growth during the complex adolescent period. Nevertheless, race- and sex-specific growth curves of pulmonary function vs. height make it easy to display and evaluate repeated measures of pulmonary function for an individual child. Race-, sex-, and age-specific regression equations based on height are provided, which permit the evaluation of growth during adolescence with improved accuracy and, more importantly, in comparison with previous observations for the same child. © 1993 Wiley-Liss, Inc.     

Improvement of “irreversible” airway obstruction by thiazinamium (Multergan®)

Thiazinamium (Multergan®, 50 mg intramuscularly) improved lung function (forced expiratory volume in one second [FEV_1.0]; forced vital capacity [FVC]) within one hour after injection in 11 men (average age 66.4 years) with chronic cough, phlegm, and dyspnea, and with severe ventilatory function loss (average FEV_1.0, 42.5% of predicted values; average FVC, 64.6%) due to prolonged exposure (≥28 years) to dust of soft hemp in industry. The increase of FEV_1.0 and of FVC after thiazinamium was significantly greater than that observed after isoproterenol inhalation in the same subjects. The acute effect of thiazinamium, which lasted at least six hours, was maintained over a one-month period of daily injections. Oral administration of 200 mg thiazinamium had little effect on FEV_1.0 and FVC. The results suggest that "irreversible" airway obstruction may be more amenable to drug treatment than is often thought.     

Comparison between reference values for FVC,FEV1, and FEV1/FVC ratio in White adults in Brazil and those suggested by the Global Lung Function Initiative 2012

OBJECTIVE:

To evaluate the spirometry values predicted by the 2012 Global Lung Function Initiative (GLI) equations, which are recommended for international use, in comparison with those obtained for a sample of White adults used for the establishment of reference equations for spirometry in Brazil.

METHODS:

The sample comprised 270 and 373 healthy males and females, respectively. The mean differences between the values found in this sample and the predicted values calculated from the GLI equations for FVC, FEV₁, and VEF₁/FVC, as well as their lower limits, were compared by paired t-test. The predicted values by each pair of equations were compared in various combinations of age and height.

RESULTS:

For the males in our study sample, the values obtained for all of the variables studied were significantly higher than those predicted by the GLI equations (p < 0.01 for all). These differences become more evident in subjects who were shorter in stature and older. For the females in our study sample, only the lower limit of the FEV₁/FVC ratio was significantly higher than that predicted by the GLI equation.

CONCLUSIONS:

The predicted values suggested by the GLI equations for White adults were significantly lower than those used as reference values for males in Brazil. For both genders, the lower limit of the FEV₁/FVC ratio is significantly lower than that predicted by the GLI equations.     

Effect of Terbutaline on Exercise Capacity and Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease

The objective of this study was to investigate the effects of a single dose of a β₂-agonist, terbutaline (Bricanyl Turbuhaler?), on resting lung function and exercise capacity in patients with chronic obstructive lung disease. Using a double-blind, placebo-controlled, randomized crossover study and outpatients from a department of pulmonary medicine at a major inner-city hospital, we examined 26 individuals with chronic obstructive lung disease who met the criteria of 40% ≤ FEV₁≤ 70% of predicted, FEV₁/FVC ≤ 70%, and ΔFEV₁≤ 200 ml 20 min after inhalation of 1 mg of terbutaline. The patients inhaled 2.5 mg of terbutaline and matched placebo. At rest, terbutaline caused significant increases in D_LCO, MVV_12sec, and all spirometric indices derived from the flow-volume loop, the increases also being significantly larger than those after inhalation of 1 mg of terbutaline for FEV₁, FVC, and PEF. The peak work rate was unchanged after terbutaline. Oxygen uptake, ventilation, and tidal volume at peak work rate increased significantly, whereas carbon dioxide elimination increased insignificantly. Cumulative oxygen uptake and carbon dioxide elimination during progressive exercise to exhaustion and 10 min of recovery were significantly higher after terbutaline. We concluded that despite significant improvements in resting lung function, inhalation of 2.5 mg of terbutaline did not increase exercise capacity, but it increased cumulative oxygen uptake and carbon dioxide elimination during exercise and recovery, presumably because of a thermogenic effect of terbutaline. Accepted for publication: 29 April 1999     

Effects of changing reference values and definition of the normal range on interpretation of spirometry

Background and objective: Recent spirometry reference studies are arguably the most valid ever performed and the ATS/ERS now recommend the National Health and Nutrition Assessment Survey (NHANES) equations for North America. It is timely to consider adopting these reference values in Australasia; however, an evaluation of the consequences of such a change is required. Methods: We analysed data from 1108 patients tested in two pulmonary function laboratories in public hospitals. Lower limits of normal (LLN) were calculated using European Community for Steel and Coal (ECSC) (1993), Knudson (1983), NHANES (1999) and Health Survey of England (HSE) (2004) equations and used to define restriction (FVC < LLN) and obstruction (FEV₁/FVC < LLN). This interpretative strategy was also compared with the GOLD definition of obstruction (FEV₁/FVC < 70%). Results: Average age for all patients (50% female) was 60 years (range: 20–91). The mean predicted FVC from NHANES and HSE were similar and consistently higher than those from ECSC and Knudson (average 270 mLs). This translates into a 76% increase in the incidence of ‘restrictive’ interpretations using NHANES data compared with ECSC and Knudson, and a smaller increase of 40% for HSE. Using FEV₁/FVC < 70% to diagnose obstruction in those over 65 years would result in false positive rates of approximately 28%. Using the same definition in a younger group (<50 years old) results in a false negative rate of approximately 14%. Conclusions: Changing to either NHANES or HSE predicted values will significantly increase the rate of ‘restrictive’ interpretation, and alter the rate of obstructive findings. The NHANES and HSE data confirm that using FEV₁/FVC < 70% to define obstruction causes misdiagnosis in elderly and younger subjects.     

Gender Differences in the Association of Individual and Contextual Exposures with Lung Function in a Rural Canadian Population

Introduction

To investigate the association of individual and contextual exposures with lung function by gender in rural-dwelling Canadians.

Methods

A cross-sectional mail survey obtained completed questionnaires on exposures from 8263 individuals; a sub-sample of 1609 individuals (762 men, 847 women) additionally participated in clinical lung function testing. The three dependent variables were forced expired volume in one second (FEV₁), forced vital capacity (FVC), and FEV₁/FVC ratio. Independent variables included smoking, waist circumference, body mass index, indoor household exposures (secondhand smoke, dampness, mold, musty odor), occupational exposures (grain dust, pesticides, livestock, farm residence), and socioeconomic status. The primary analysis was multiple linear regression, conducted separately for each outcome. The potential modifying influence of gender was tested in multivariable models using product terms between gender and each independent variable.

Results

High-risk waist circumference was related to reduced FVC and FEV₁ for both genders, but the effect was more pronounced in men. Greater pack-years smoking was associated with lower lung function values. Exposure to household smoke was related to reduced FEV₁, and exposure to livestock, with increased FEV₁. Lower income adequacy was associated with reduced FVC and FEV₁.

Conclusion

High-risk waist circumference was more strongly associated with reduced lung function in men than women. Longitudinal research combined with rigorous exposure assessment is needed to clarify how sex and gender interact to impact lung function in rural populations.

     

Forced expiratory maneuvers in children aged 3 to 5 years

There is no consensus about reproducibility and reliability of spirometry in young children. We evaluated forced expiratory maneuvers from 98 children aged 3 to 5 years with a variety of respiratory disorders before and after bronchodilator treatment. Forced vital capacity (FVC) and forced expiratory volume in 1 sec (FEV,) were analyzed for reproducibility by the American Thoracic Society criteria and for reliability based on the coefficient of variation (CVYo). Over 90% of the patients cooperated, however, while 95% could exhale for at least 1 second, very few generated an FEV, on all 6 “best” efforts. This clearly improved with age. Of all patients nearly 60% performed reproducible pre-and postbronchodilator sets of FVC but only 32% performed reproducible sets of FEV₁. Based on the CV%, those patients who could reproducibly perform an FVC and FEV, did it quite reliably (mean CV%, 9.38 and 7.01 for FVC and FEV₁, respectively). We conclude that while some very young children can perform spirometry, reliability of performance cannot be assumed in this age group. Pediatr Pulmonol. 1994;18:144–149. © 1994 Wiley-Liss, Inc.